These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 6180142

  • 1. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
    Jellinger K.
    J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
    Schneider E, Hubener K, Fischer PA.
    Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
    Marsden CD.
    Drugs; 1998 Apr; 55 Suppl 1():17-22. PubMed ID: 9483166
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Parkinson's disease with dopamine agonists: a review.
    Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M.
    Am J Med Sci; 1979 Apr; 278(1):65-76. PubMed ID: 39452
    [Abstract] [Full Text] [Related]

  • 5. Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease.
    Markham A, Benfield P.
    CNS Drugs; 1997 Apr; 7(4):328-40. PubMed ID: 27520755
    [Abstract] [Full Text] [Related]

  • 6. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KD.
    Cochrane Database Syst Rev; 2001 Apr; 2001(1):CD001519. PubMed ID: 11279721
    [Abstract] [Full Text] [Related]

  • 7. Treatment of parkinson's disease with bromocriptine.
    Lieberman A, Kupersmith M, Estey E, Goldstein M.
    N Engl J Med; 1976 Dec 16; 295(25):1400-4. PubMed ID: 989885
    [Abstract] [Full Text] [Related]

  • 8. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan 16; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN, Neophytides A, Leibowitz M, Gopinathan G, Pact V, Walker R, Goodgold A, Goldstein M.
    Adv Neurol; 1983 Jan 16; 37():95-108. PubMed ID: 6858782
    [Abstract] [Full Text] [Related]

  • 10. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, PKDS009 Study Group.
    CNS Drugs; 2004 Jan 16; 18(11):733-46. PubMed ID: 15330687
    [Abstract] [Full Text] [Related]

  • 11. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD, Debono AG, Marsden CD.
    J Neurol Neurosurg Psychiatry; 1976 Nov 16; 39(11):1101-8. PubMed ID: 1036999
    [Abstract] [Full Text] [Related]

  • 12. Bromocriptine in Parkinson disease.
    Lieberman AN, Goldstein M.
    Pharmacol Rev; 1985 Jun 16; 37(2):217-27. PubMed ID: 3901046
    [Abstract] [Full Text] [Related]

  • 13. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001 Jun 16; (1):CD001517. PubMed ID: 11279719
    [Abstract] [Full Text] [Related]

  • 14. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD, Delgado MR.
    Clin Neuropharmacol; 1985 Jun 16; 8(1):73-7. PubMed ID: 3978651
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2000 Jun 16; 2001(3):CD001517. PubMed ID: 10908504
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ropinirole: a review of its use in the management of Parkinson's disease.
    Matheson AJ, Spencer CM.
    Drugs; 2000 Jul 16; 60(1):115-37. PubMed ID: 10929932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.